These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25416753)

  • 1. Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.
    Memoli MJ; Czajkowski L; Reed S; Athota R; Bristol T; Proudfoot K; Fargis S; Stein M; Dunfee RL; Shaw PA; Davey RT; Taubenberger JK
    Clin Infect Dis; 2015 Mar; 60(5):693-702. PubMed ID: 25416753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dose-finding Study of a Wild-type Influenza A(H3N2) Virus in a Healthy Volunteer Human Challenge Model.
    Han A; Czajkowski LM; Donaldson A; Baus HA; Reed SM; Athota RS; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
    Clin Infect Dis; 2019 Nov; 69(12):2082-2090. PubMed ID: 30770534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.
    Watson JM; Francis JN; Mesens S; Faiman GA; Makin J; Patriarca P; Treanor JJ; Georges B; Bunce CJ
    Virol J; 2015 Feb; 12():13. PubMed ID: 25645025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09.
    Bradley-Stewart A; Jolly L; Adamson W; Gunson R; Frew-Gillespie C; Templeton K; Aitken C; Carman W; Cameron S; McSharry C
    J Clin Virol; 2013 Sep; 58(1):100-7. PubMed ID: 23790455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    Fullen DJ; Noulin N; Catchpole A; Fathi H; Murray EJ; Mann A; Eze K; Balaratnam G; Borley DW; Gilbert A; Lambkin-Williams R
    PLoS One; 2016; 11(1):e0145902. PubMed ID: 26761707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.
    Njuguna H; Ahmed J; Oria PA; Arunga G; Williamson J; Kosgey A; Muthoka P; Mott JA; Breiman RF; Katz MA
    Vaccine; 2013 Sep; 31(41):4662-7. PubMed ID: 23859843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model.
    Han A; Poon JL; Powers JH; Leidy NK; Yu R; Memoli MJ
    BMC Infect Dis; 2018 Jul; 18(1):353. PubMed ID: 30055573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of influenza A(H1N1)pdm09 virus shedding: duration is affected by severity, but not age.
    Fielding JE; Kelly HA; Mercer GN; Glass K
    Influenza Other Respir Viruses; 2014 Mar; 8(2):142-50. PubMed ID: 24299099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza.
    Jia N; Gao Y; Suo JJ; Xie LJ; Yan ZQ; Xing YB; He L; Liu YX
    Chin Med J (Engl); 2011 May; 124(10):1576-9. PubMed ID: 21740820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of influenza A(H1N1)pdm09 virus circulating during the 2009 outbreak in Thua Thien Hue, Vietnam.
    An le V; Bao Chi le T; Bach NH; Hai Duong HT; Deligios M; Alberti A; Cappuccinelli P
    J Infect Dev Ctries; 2013 Mar; 7(3):235-42. PubMed ID: 23493002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.
    Hansen C; Desai S; Bredfeldt C; Cheetham C; Gallagher M; Li DK; Raebel MA; Riedlinger K; Shay DK; Thompson M; Davis RL
    J Infect Dis; 2012 Oct; 206(8):1260-8. PubMed ID: 22859826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
    Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load.
    Cheng PK; Wong KK; Mak GC; Wong AH; Ng AY; Chow SY; Lam RK; Lau CS; Ng KC; Lim W
    J Clin Virol; 2010 Feb; 47(2):182-5. PubMed ID: 20022296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection--a retrospective comparative analysis.
    Redlberger-Fritz M; Hirk S; Buchinger D; Haberl R; Hell M; Perkmann-Nagele N; Kundi M; Popow-Kraupp T
    J Med Virol; 2014 Jun; 86(6):1048-55. PubMed ID: 24615722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Feasibility of Using Noninvasive Wearable Biometric Monitoring Sensors to Detect Influenza and the Common Cold Before Symptom Onset.
    Grzesiak E; Bent B; McClain MT; Woods CW; Tsalik EL; Nicholson BP; Veldman T; Burke TW; Gardener Z; Bergstrom E; Turner RB; Chiu C; Doraiswamy PM; Hero A; Henao R; Ginsburg GS; Dunn J
    JAMA Netw Open; 2021 Sep; 4(9):e2128534. PubMed ID: 34586364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
    Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
    J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
    Mallory RM; Yi T; Ambrose CS
    Vaccine; 2011 Jun; 29(26):4322-7. PubMed ID: 21513761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.